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One of the most common causes of physical disability acquired during childhood is cerebral 
palsy (CP). Due to improvements in medical care over the past decades, almost all children 
with CP survive into adulthood nowadays. In addition, based on a stable incidence rate and 
longevity of individuals with CP, currently most persons with CP are adults. Therefore, it is 
appropriate to draw awareness to focus on rehabilitation in adults with CP.  
Due to the nature of their physical disability, adults with CP are at risk to an inactive lifestyle, 
which can lead to increased health risks. Physical inactivity may be the predisposition to 
developing a cycle of deconditioning, in which reduced levels of PA (physical activity) may 
lead to lower levels of physical fitness. Lower levels of physical fitness cause individual’s 
with CP to expend more energy during daily activities such as walking. As a consequence, 
individuals with CP may experience earlier fatigue, pain or other factors that increase the 
impact of the disorder on daily functioning. It is therefore important to intervene in this 
vicious cycle of physical inactivity. This thesis provides an overview of the methods used to 
record PA and reports on PA levels in adults with CP.  
The literature review evidently showed that adults with CP were less physically active 
compared to TD (typically developed) peers and spent more time in sedentary behaviour 
compared to TD adults. Various methods have been shown to be available to assess levels of 
PA, such as questionnaires, pedometers, and more advanced accelerometers that allow for 
measuring acceleration in three directions (x-y-z axes). Previously, research studies’ most 
commonly used hip-worn devices among adults with CP to assess PA levels, such as the 
Actigraph that has been used and validated in various populations with and without 
disabilities. Unfortunately, the Actigraph is not water resistant, which does not allow 
individuals to continuously wear the device. Alternatively, wrist-worn devices can be used to 
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assess PA levels, such as the Polar Loop 2, which is convenient to wear and water-resistant. 
However, no previous research has proven the validity of the Polar Loop 2 to assess PA 
levels in a cohort with CP. In addition, most studies focused on adults with CP in developed 
countries, while no studies have been conducted in developing countries.  
Therefore, the aim of the second study was to determine differences in PA between adults 
with CP and TD adults living in South Africa, assessed with the Actigraph and Polar Loop 2 
accelerometers. In addition, we aimed to determine the validity of the Polar Loop 2 compared 
to the Actigraph for different levels of PA. This study showed that adults with CP were less 
physically active than TD adults, based on findings that the number of steps taken per day 
were substantially lower, they spent more time being sedentary and less time in low and 
moderate intensity PA. The Polar Loop 2 showed to be a valid measure for PA in adults with 
CP and TD adults. Since the Polar Loop 2 is water-resistant and convenient to wear it can be 
a useful tool to measure PA in clinical practice. 
The reduced levels of PA presented in this thesis highlight that adults with CP are at risk of 
reduced fitness levels and secondary complications during daily life activities. This cycle of 
deconditioning may progress during ageing in adults with CP. More PA and exercise, at the 
correct intensity and duration, can break the barrier of this vicious cycle. Regular exercise can 
have a variety of beneficial effects on the health of adults with CP. For example, it may 
reduce the incidence of obesity, improve muscle function and muscle strength. Furthermore, 
exercise can reduce the incidence of chronic health conditions like diabetes, cardiovascular 
diseases and osteoporosis. In order to avoid health issues at older ages and to prevent inactive 
lifestyles, it is important to encourage a healthy and active lifestyle during early adulthood to 
promote physically active when growing older. Regular exercise also positively influences 








It is generally known that low levels of physical activity (PA) are associated with health risk 
factors and chronic disease.1 Individuals living with physical disabilities such as Cerebral 
Palsy (CP) are prone to being less physically active than their typically developed (TD) 
peers. A result of lower PA levels is the predisposition to developing a cycle of 
deconditioning, in which reduced levels of PA may lead to secondary conditions such as; 
pain fatigue and/or cardiovascular conditions that could further attenuate this deconditioning 
cycle. Decreased levels of moderate to vigorous physical activity (MVPA) with increased 
sedentary behaviour is associated with metabolic syndrome risk factors of cardiovascular 
disease, type-2-diabetes, dyslipidaemia, obesity and generalized inflammatory markers.2  
Therefore, investigating the PA status and patterns in adults with CP will be potentially 
informative for themselves, in addition to clinicians and care-givers when considering health 
and wellness from a psychological, physical and economical perspective. The aim of this 
literature review is to provide insight into CP, how to measure PA and the levels of PA 
reported in adults with CP.  
CEREBRAL PALSY 
Aetiology and epidemiology 
CP is the most common cause of physical disabilities in children.3–6 It is caused by a 
neurological disorder that occurs before, during or after delivery which is characterised by a 
non-progressive nature.2 As a consequence of this neurological disorder, children with CP 
often show impairments in; growth, posture, and motor development.2 CP serves as an 
umbrella term constituting a spectrum of disorders as a result of the permanent 
encephalopathy.5 The outcome of early-onset encephalopathy predisposes neurological 
deficits including; ‘disturbances in cognition, perception, sensation, communication and 
behavioural problems’.6 
The population based prevalence of CP varies amongst registries and historically reports 
estimates of 1.5 to 2.5 per 1000 live births.3, 6, 7 South African data however, remain 
inconclusive with estimates of between 1% and 8% of the population being affected.8, 9 
Irrespective of the prevalence, advancements in neonatal care over the recent decades have 
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lowered the mortality of premature infants, contributing to a modest increase in its 
prevalence.10 Thus with the expected rise in adolescence and adults with CP, compensated 
strain on the health-care system has prompted the emphasis of management of all markers of 
activities of daily living (ADL) including participating in adjusted physical activity.11 These 
markers of ADL such as mobilization, washing and dressing are affected due to the 
deteriorating clinical expression of the original neonatal injury, resulting in the inability to 
control movement and posture while definitively affecting the peripheral joints.  
The consequential conditions which present with CP are a maturation of the upper motor 
neuron (UMN) syndrome. (Figure 1) The UMN syndrome is divided into and including the 
sensory pathology, as the loss of inhibition to the lower motor neurons (LMN) and the motor 
pathology, as the loss of connection to the LMN’s.10 




The classification of CP is commonly based on either the 1) physiological, 2) topographical 
or 3) functional components. Classification is important to determine suitable management 
for individuals with CP. 
Physiological classification 
According to the Surveillance of Cerebral Palsy (SCPE), there are three predominant types 
based on the physiological classification, Spastic, Dyskinetic (which includes dsytonia and 
choreo-athetoid) and ataxic.4,6,9 The subtypes are classified by the type of movement 
impairment and location of the brain lesion. Spastic CP commonly presents with damage to 
the motor cortex, dyskinetic CP is evident in lesions at the basal ganglia and ataxic CP is 
consistent with damage at the cerebellum.14 Cerebral lesions then coincide with damage to 
the body’s peripheral nerves and limbs as part of the UMN syndrome. 
Topographical distribution 
The topographical distribution provides a peripheral illustration of the limbs that are most 
affected by CP (Figure 2). In unilateral CP, one side of the body is affected, while in bilateral 
CP both sides are affected. Unilateral CP is referred to as monoplegia when one limbs is 
affected (usually the lower extremity), or hemiplegia, when both the upper and lower limbs 
are affected (usually with the upper limb being more affected).15 The presentation of bilateral 
CP can be divided into diplegia, in which both lower limbs are affected, triplegia in which 
both lower limbs and a single upper limb are affected, quadriplegia, in which all limbs are 
affected.15 
Figure 2: Topographical classification of Cerebral Palsy.16 
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Level of gross-motor function 
In addition to the physiological and topographical classifications, the Gross Motor Function 
Classification System (GMFCS) has widely been accepted as a tool to classify the severity of 
functional disability of children with CP16 and has been expanded and revised for the 
assessment of adults and adolescents with CP (Figure 3).17,18 Observations seen within the 
GMFCS are based on the patients’ usual performance in the context of the home, school and 
community setting. 




Ageing with Cerebral Palsy 
There is an increase in the survival rate of children with CP into adulthood.19,20  The increased 
survival rate creates a compensated strain on the adult health-care system, that has prompted 
the emphasis of management of all markers of activities of daily living (ADL) including 
participating in adjusted PA.4 The long-term effects of reduced PA and increased sedentary 
time can lead to a greater risk of developing secondary health problems, such as metabolic 
dysfunction, cardiovascular disease and poor bone density.13,21–24 The increase in the 
transition from childhood into adulthood warrants the need for objectively monitored tools to 
be used to conduct evidence based-rehabilitation, research and practice. 
PHYSICAL ACTIVITY 
Individuals with CP are prone to develop secondary consequences, which may include but are 
not limited to pain, stiffness, poor balance and fatigue.23,25,26 All of these problems may lead 
to a further reduction in PA levels, which in turn can cause deterioration in physical 
functioning and a loss of mobility initiating at early adulthood.3 PA contributes to the 
prevention of chronic disease,1,27 depending on its modality, intensity and frequency.  It is 
therefore important to monitor PA levels in adults with CP in order to maintain and/or 
improve PA levels and provide guidelines that are suitable for populations with physical 
impairments, such as CP. 
Definition of physical activity 
PA is defined as any body movement that results in energy expenditure.1 More specifically 
the term ‘habitual physical activity’ (HPA) has been used, which refers to the ‘pattern and 
magnitude of bodily movements during ADL’ and includes domains such sleep, rest, work 
and leisure.28 In addition to measuring PA, sedentary behaviour is defined as any waking 
activity which involves low energy expenditure in a reclined or seated posture.1,29 
Recommendations for physical activity 
The World health organization has recently updated PA guidelines for adults: being active for 
at least 30 minutes of moderate-to-vigorous intensity PA per day and that sedentary time 
ought to be minimized as much as possible.27 Individuals with CP may be a vulnerable 
population who find it challenging to meet these PA guidelines, because of their limitations 
in physical functioning.27,28,30 
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Methods to obtain physical activity data 
Several methods are available to obtain PA levels in daily life, such as accelerometry and PA 
questionnaires.31 The validity and accuracy of questionnaires, as reported by Troaino et al. 
(2015), is questionable as it self-reports the total duration of activity perceived by the 
individual and does not appropriately quantify activity-related movement.32 Based on 
questionnaires, individuals with CP have been previously reported to be less physically 
active,33 however the same trend has been seen in TD adults when self-reporting PA.34 The 
reliance of self-report for PA is therefore questioned. This highlights the need for monitoring 
PA using quantitative measurements, like accelerometry, which can help to provide estimated 
goals for targeted intervention of PA in CP.  
ACCELEROMETRY 
Accelerometers are wearable devices that are commonly used to objectively quantify, 
characterize and monitor PA behaviour. Previously, physical activity was recorded by using 
step counts, however no information could be obtained about intensity or the type of daily 
PA.32,35Nowadays, accelerometers are able to record accelerations in different planes (antero-
posterior, medio-lateral and vertical), which allows for accurate outcome measures in 
individuals’ PA and sedentary behaviour in terms of time, intensity and type.30,35 In general, 
accelerometers are fairly light and recordings are non-invasive.28,36 
Accelerometers may be worn around the hip, such as the Actigraph or the wrist, which may 
include the Polar band, Fitbit, Smartband, Vivofit. Hip worn devices are among the most 
commonly used accelerometers.  The actigraph has been validated to measure PA in general 
populations,37 as well as in individuals with CP.30 Most of these hip worn devices are not 
water-resistant; hence it needs to be removed in cases of showering, bathing, swimming or 
during excessive sweating.23,38 In addition, emerging research suggests that participants 
consider wrist worn devices to be less burdensome, which may result in higher levels of 
compliance.39 Furthermore wrist worn devices are generally more cost-effective compared to 
hip worn devices, such as the Actigraph.35  Therefore a recent shift toward wrist worn activity 
monitoring is noticeable in the literature.39,40 
Using device specific software, accelerometers can be used to obtain the time that individuals 
partake in different levels of intensity, either classifying PA into laying, sitting, standing, 
walking and running, or sedentary and low, moderate and high intensities. Sedentary 
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behaviour has become increasingly popular to assess, since previous research has shown that 
there is reasonable evidence for a causal relationship between sedentary behaviour and all-
cause mortality.41 
PHYSICAL ACTIVITY LEVELS IN ADULTS WITH CEREBRAL PALSY 
Table 1 provides an overview of the literature that reports on PA levels in adults with CP, 
including details regarding the ages, gender, sample size, GMFCS, the period of wear-time 
and the outcome measures which were evaluated. 
Ryan et al (2014) showed that adults with CP spent less time in light, moderate and vigorous 
PA than TD peers.13 In addition, adults with CP were reported to spend 523min in sedentary 
behaviour, while TD adults spent about 420min of the day being sedentary. Ryan et al (2014) 
also showed that adults with CP classified in GMFCS level I, spent more time in moderate 
and vigorous PA compared to levels’ II and III, and adults with CP classified in GMFCS 
level II spent more time being moderately physically active compared to level III.13 These 
differences between GMFCS levels may evidently be explained by differences in functional 
mobility. Interestingly, Ryan et al (2014) found no difference in the time adults with CP 
classified in GMFCS level I spent in low, moderate and vigorous PA compared to TD peers, 
as well as time spent in sedentary behaviour.13  
In consistence with the findings of Ryan et al (2014), Nieuwenhuijsen et al (2010) showed 
that GMFCS level was a strong predictor of PA levels in adults with bilateral spastic CP,38 
which is in accordance with previous research that included children and adolescents with 
CP.42 Claridge et al (2015) showed that adults with CP classified in GMFCS levels’ III-V 
spent significantly more time being sedentary than adults with CP classified GMFCS I and 
II.30  These findings highlight the importance of the impact that GMFCS level has on mobility
and PA.
A cross-sectional study conducted by Van der Slot et al (2007) reported that adults with 
unilateral spastic CP were as physically active as their TD peers.43 In contrast, 
Nieuwenhuijsen et al (2010) reported that adults with bilateral spastic CP were less 
physically active than TD peers.38 This difference between subtypes of spastic CP was 
confirmed by Ryan et al (2014), whom showed that adults with bilateral spastic CP spent 
more time in sedentary behaviour compared to adults with a unilateral spastic involvement.13 
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The relationship between unilateral/bilateral CP and PA and sedentary behaviour has been 
illustrated in Ryan et al (2014) in which the entire cohort consisted of 60% bilateral CP and 
40% unilateral CP, more specifically a greater population of bilateral CP constituted the 
GMFCS III level (90%) compared the unilateral CP (10%).13 These findings convey the 
topographical distribution of CP impairments and its relationship with PA, however this 
relationship has not been extensively studied in a mixed group of CP, considering the various 
types of CP (choreoathetoid, ataxic, dystonic) and for PA recommendations for these 
particular subgroups of CP. 
Studies by Nieuwenhuijsen et al (2010) and Van der Slot et al (2007) reported that 
individuals with CP did not meet recommended PA guidelines as documented by the World 
Health Organization (WHO).38,43 While these guidelines recommend individuals to be 
physically active for 150min per week, from findings reported by Ryan et al (2014) adults 
with CP are estimated to be physically active for only 46min per week.13 Ryan et al (2014), 
however, showed that adults with CP classified in GMFCS I were active for a mean of 27min 
per day in moderate to vigorous activity, resulting in over half of their cohort with GMFCS I 
meeting the guidelines. While these studies highlight the deficits in PA compared to 
recommended guidelines, their heterogeneity in distribution do not effectively convey PA 
measurements across all GMFCS levels. 
Nieuwenhuijsen et al (2010) suggested that a negative cycle of deconditioning may form as a 
result of inactivity leading to lower physical fitness levels. Subsequently, these lower fitness 
levels may then lead to further detriments in function which may lead to further inactivity.38 
In addition, Nieuwenhuijsen et al (2010) showed that in their cohort only 39% of adults with 
CP had one or two periods of continuous activity, with no participants involved in activity 
greater than 10min and the majority being involved in activity lasting 10-30secs.38 Thus, 
being less physically active may be particularly detrimental for adults with CP who show 
more severe limitations in gross motor function. Furthermore, Nieuwenhujsen et al (2010) 
highlighted that inactivity and lower fitness levels may ‘negatively affect health-related 
quality of life (HRQOL).38  
The increased risk of developing cardiometabolic disease in adults with CP as a result of a 
negative physical deconditioning cycle may be associated with pain and fatigue.23,44 Jahnsen 
et al (2004) reported a positive association with the lack of PA and increased pain, of which 
may result in further physical deterioration. McPhee et al (2017) documented a ‘significant 
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negative relationship between MVPA and fatigue’ and suggested that PA intensity be 
targeted for reducing the loss in physical functioning.23 Russchen et al (2014) highlighted the 
trend in lower fatigue associated with a higher cardiopulmonary fitness.45 PA may therefore 
improve the experience of both pain44 and fatigue23 which has a direct relationship to an 
improvement in HRQOL and participation in life situations.6 
CONCLUSION 
This literature review evidently showed that adults with CP were substantially less physically 
active compared to TD peers and spent considerably more time in sedentary behaviour. These 
lower levels of PA may result in a deconditioning cycle that progresses with age. PA levels 
can be assessed in a variety of ways, with many studies that used hip-worn devices, while 
wrist-worn devices, such as the Polar Loop 2, may be more convenient to wear and therefore 
may improve feasibility in clinical practice. In addition, most studies focused on adults with 
CP in developed countries, while no studies have been conducted in developed countries. 
Therefore, it would be interesting to investigate the PA levels of adults with CP residing in 
developing countries like South Africa and to determine the validity of wrist-worn devices, 
the Polar Loop 2, in a population with CP. 
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Sample size CP classification (GMFCS) Accelerometer type Test period Main findings 
McPhee et al.23 
Adults: 
Mean=33.7 (SD12.3) 






















Hip-worn Actigraph GT3X 
Wrist-worn Actigraph GT3X 
-Atleast 5hours p/day
-7 consecutive days
-GMFCS III-IV displayed increased
sedentary time with less breaks from
being sedentary regardless of cut-
points used
-Hip and wrist accelerometers feasible
for population








Vitamore (VM) system (3 
recorders placed, at trunk and 
thighs) 
72 hours (randomly selected, 
consecutive days) 
-Decreased levels of PA in young
adults
-no relationship between fatigue and
PA
Ryan et al.13 
Adults: 
 Mean=36.5 (SD=12.5) 




III=10 RT3 (hip-worn) 
7 consecutive days on the right 
hip 
-Adults with CP spend less time in
light, moderate and vigorous PA
-Inverse relationship between 
GMFCS, PA and sedentary time 












Activity Monitor (AM), hip-
worn 48 hours of continuous wear, on random days of week 
- Inverse relationship between PA and
GMFCS in bilateral spastic CP
-Personal and CP-related factors other
than GMFCS not related to PA
Van de Slot et 
al.43 
Adults: 
Mean= 28 (SD=3) 
Males=7, Females=9 
N=16 I=16 Activity Monitor (AM), hip-worn 
48 hours of continuous wear, on 
random days of week 
-No difference in PA between CP
hemiplegia and TD
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AIM To compare the physical activity (PA) status between adults with Cerebral Palsy (CP) and 
typically developed (TD) adults. In addition, to determine the validity of the Polar Loop 2 capturing 
PA in comparison to the Actigraph (wGT3X) in adults with CP and TD adults.  
METHODS Participants wore both the Polar Loop and Actigraph for seven consecutive days. The 
number of steps and time participants spent sedentary and in low, moderate and high intensity PA's 
were recorded. 
RESULTS A total of 46 participants were enrolled, consisted of adults with CP (n=26; median 
[IQR] = 34.5 [30.5-36.3] years) and TD adults (n=30; median [IQR] = 34.0 [29.8-35.2] years. 
Adults with CP accumulated less steps, spent more time being sedentary and spent less time in low 
and moderate PA intensities than TD adults. No difference in high intensity PA was observed 
between adults with CP and TD adults. Strong correlation was observed between the Polar Loop 2 
and Actigraph for the number of steps and across all PA intensity levels. 
INTERPRETATION Results showed that adults with CP are less physically active than TD 
adults, except during high intensity PA. In addition, the Polar Loop 2 showed to be a valid tool to 
measure PA in adults with CP and TD adults. Since the Polar Loop 2 is convenient to wear, it can 
be useful to measure PA in clinical practice. 
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WHAT THIS PAPER ADDS 
• Adults with cerebral palsy are less physically active than their typically developed peers,
except during high intensity physical activity.
• Adults with cerebral palsy do not meet international guidelines for physical activity.
• Polar Loop 2 showed to be valid to measure physical activity in adults with cerebral palsy




Cerebral palsy (CP) is one of the most common causes of physical disability in childhood, with a 
prevalence of 1.5 to 2.5 per 1000 live births.1,2 CP is described as a non-progressive lesion of the 
brain that occurs before, during or after delivery.3 This cerebral lesion causes impairments which 
result in problems with movement and posture.4 Although CP is a non-progressive condition, these 
primary motor impairments often lead to limitations in gross motor function and daily activities 
such as personal care and mobility.5  
As a result of these limitations in daily activities, individuals with CP are prone to being or 
becoming less physically active, which has been shown to be associated with negative risk factors 
for obesity and cardio metabolic disease.6 The guidelines for physical activity (PA), published by 
the World Health Organization (WHO), document recommendations for adults (18-64years) to be 
physically active for at least 150min of moderate intensity PA throughout the week, or do at least 
75min of vigorous intensity PA throughout the week.7 Young adults with CP, however, appeared to 
be less physically active than their typically developed (TD) peers,8,9 indicative of not meeting PA 
activity guidelines. In addition, literature has shown that individuals with CP have reduced physical 
fitness levels.10,11 The combination of reduced PA and fitness levels can lead to a sedentary lifestyle 
which may further deteriorate the physical status of those with CP,8 and furthermore result in 
fatigue and a decreased health-related quality of life (HRQOL).12,13 The impact of reduced PA 
associated with CP may therefore lead to a vicious cycle of deconditioning, and thus it is imperative 
for these individuals’ to be physically active to improve their fitness levels and HRQOL. 
In order to identify those individuals who are at risk for inactive lifestyles and secondary 
complications (obesity, cardio metabolic disease), it is essential to monitor PA. Troaino et al. 
(2015) reported that the validity and accuracy of self-report questionnaires only accounted for the 
individual’s perception of their PA, therefore not appropriately quantifying PA.14 Similarly, a study 
Research manuscript 
36 
with individuals with CP 15 and TD adults16, observed a similar trend when self-reporting PA, using 
questionnaires. Alternatively, PA can be measured using accelerometry. Accelerometers provide 
accurate measures of the type, time and intensity of PA and sedentary time,17,18 and are typically 
worn around the waist or wrist. The Actigraph is a waist worn accelerometer, that has been used as 
a golden standard for PA research in TD cohorts and cohorts with CP.17,19–21 The Actigraph (wGTX 
+BT) has been validated using double-labelled water as a criterion measure to differentiate between
PA intensities in individuals with CP.19,20,22 The Actigraph (wGTX + BT) is however not water 
resistant,13 and is more expensive than wrist worn devices.18 Alternatively, the Polar Loop 2 is a 
water resistant, wrist worn accelerometer,23 which might imply a greater degree of compliance due 
to its comfort on the wrist and user friendly design when attaining long-term PA measurements. 
Accordingly, the Polar Loop 2 may be a more suitable instrument for research. However, no 
previous studies have validated the Polar Loop 2 in adults with CP and TD adults. 
Therefore, the aim of this study was to determine differences in PA between adults with CP and TD 
adults, assessed with the Actigraph and Polar Loop 2 accelerometers. In addition, we aimed to 





In this observational comparative study PA was obtained from adults with CP and matched TD 
adults. This study was approved by the Human Research Ethics Committee at the University of 
Cape Town, South Africa (HREC 014 2017), and was conducted in accordance with the 
International Declaration of Helsinki for human participation in research.1 
Participants 
Adults with CP were eligible for inclusion if they had a medical diagnosis of CP and a Gross Motor 
Function Classification System (GMFCS25) level between I and V. The age limit for participants 
was 40 years and participants had to live within a 100km radius of Cape Town, South Africa. 
Participants were excluded if they had any neuromuscular or physical disorder unrelated to CP, 
were unable to effectively comprehend instructions and if they were unable to communicate in 
English or Afrikaans. TD adults that were recruited, included those that did not have a medical 
diagnosis of CP or any other neurological disease and adults who designated in a similar radius as 
adults with CP. TD adults were excluded should they not be able to comprehend instruction 
pertinent to the research protocol. TD adults were matched for age, gender and socio-economic 
status (SES). 
Procedure and data collection 
During the first visit, participants were addressed on the study purpose and testing requirements. 
After agreeing to participate, they signed the informed consent. Participants’ date of birth was noted 
and height and weight were obtained. The SES was estimated based on housing density, by dividing 
the number of residents in the house by the number of rooms in the house, excluding the bathroom 





PA levels were obtained using the hip-worn Actigraph (wGT3X + BT) and wrist-worn Polar Loop 
2, which were worn at the same time continuously for seven consecutive days and followed similar 
instructions regarding the removal and protection of the two accelerometers. 
The Actigraph (Actigraph Inc., Pensacola, Florida, USA, mass: 19grams dimensions: 4.6 x 3.3 x 
1.5cm; Figure 1a) was positioned anteromedially to the non-dominant hip.17,27,28 Since the 
Actigraph is not water resistant, participants were asked to remove the Actigraph prior to bathing, 
showering or swimming, and to wear to it over the clothes in case of excessive sweating. The 
Actigraph measured the magnitude of movement triaxially, with a sampling frequency of 50Hz. 
Using ActiLife software, accelerations were digitally filtered to eliminate non-human motion and 
subsequently a composite vector magnitude was computed from the three axes. In the current study, 
data was reported as counts per 30 seconds. Cut-off points (Actilife software: Troiano) were used to 
generate the following outcome measures: total number of daily steps and time (minutes) spent 
during laying and sitting (defined as sedentary), standing (low intensity), walking (moderate 
intensity) and running (high intensity). The Actigraph was able to differentiate between different 
intensities of walking and has excellent classification accuracy for moderate intensity PA.19,20,22  
The Polar Loop 2 (Polar Electro Ltd., Kempele, Finland: mass: 38grams; dimensions: 1.1 x 1.0; 
Figure 1b) was worn around the non-dominant wrist consecutively. Black tape was placed on the 
Polar Loop 2 display to prevent feedback to the participant during data collection. Using the 
PolarFlow software the following outcome measures were extracted: total number of daily steps and 
time (minutes) spent during, sedentary, low, moderate and high intensities. Related Polar devices 
have been used in previous research,27,28 the Polar Loop 2 has not been validated yet. 
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Figure 1: a) Accelerometer Actigraph GT3X Figure 1: b) Accelerometer Polar Loop 2 
Statistical analysis 
Descriptive statistics were used to summarize the demographic characteristics of the participants. 
The Shapiro-Wilk test was used to determine whether the data was normally distributed. Data 
showed to be non-normally distributed and were therefore presented as median and interquartile 
ranges (IQR). In addition, differences in the daily step count and time spent sedentary, and in low, 
moderate and high intensity PA (for the Actigraph and the Polar Loop 2) were investigated using 
Mann-Whitney U tests.  
Interclass correlation coefficient (ICC) was calculated (absolute agreement, two-way random, single 
measure with 95% confidence agreement) to examine agreement between time periods per day and 
step counts derived from the Polar Loop 2 and Actigaph. The following classification was used: 
ICC below 0.50 was considered a poor correlation, 0.50 to 0.75 was considered moderate, 0.75 to 
0.90 was considered strong and 0.90 or higher was considered an excellent correlation.14 Finally, 
Bland-Altman plots were created to evaluate the mean bias and the limits of agreement between the 
devices. All statistical analyses will be performed using IBM SPSS (version 25.0; IBM Armonk, 







Twenty-eight adults with CP participated in current study, of which two participants had incomplete 
data sets and were excluded for further analyses. The twenty-six adults with CP who were included 
matched with thirty TD adults for gender, age, BMI (Body Mass Index) and SES (Table 1). Six 
adults with CP were classified as GMFCS I (23%), six as GMFCS II (23%), eight as GMFCS III 
(30%), three as GMFCS IV (12%) and three as GMFCS V (12%). Four adults with CP were 
diagnosed with spastic hemiplegia (15%), seventeen with spastic diplegia (65%), two with spastic 
quadriplegia (8%), two with ataxic (8%) and one with athetoid (4%). 
Table 1. Participants’ characteristics of adults with CP (n=26) and TD adults (n=30) 
Variable Adults with CP 
n (%) / median [IQR] 
TD adults 
n (%) / median [IQR] t/χ p 
Gender, m/f n (%) 10 (38%) / 16 (62%) 10 (33%) / 20 (67%) 0.335 0.563 
Age (years) 34.5 [30.5 – 36.3] 34.0 [29.8 – 35.2] 387.5 0.780 
BMI (kg/m2) 26.6 [22.2 – 35.4] 28.1 [22.9 – 32.9] 396.5 0.892 
SES  1.2 [0.8 – 1.7] 1.3 [1.0 – 1.7] 388.0 0.783 
Abbreviations: IQR, interquartile range; SES, socio-economic status; BMI, Body Mass Index; and GMFCS, 
Gross Motor Function Classification System. 
Levels of activity 
As a total, 155 valid days were recorded in adults with CP and 187 valid days in TD adults and 
included in the analyses. The mean number of valid days recorded was 6.0 days per adult with CP 
and 6.2 days per TD adult.  
The total number of steps and the time participants spent in different physical intensity levels 
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assessed with the Actigraph and Polar Loop 2 are presented in Table 2. The number of steps per 
day in adults with CP was significantly lower than in adults with TD (p<0.001). Adults with CP 
spent more time sedentary (p<0.001), while TD adults spent more time in low (p<0.001) and 
moderate (p<0.001) intensity. No difference was observed between TD adults and adults with CP in 
time spent in high intensity. 
Table 2. Outcomes of accelerometers for adults with CP (n=26) and TD adults (n=30) 
Variable Adults with CP 
median [IQR] 
TD adults 
median [IQR] U p 
Actigraph 
 Steps (number/day) 3047 [1059 – 6854] 7848 [5863 – 12852] 136.0 <0.001 
Intensity (min/day) 
Sedentary time  1208 [1130 – 1311] 1055 [1021 – 1098] 117.0 <0.001 
Low intensity 210 [100 – 284] 356 [319 – 399] 83.0 <0.001 
Moderate intensity 5 [2 – 30] 22 [9 – 38] 252.0 0.023 
High intensity 0 [0 – 1] 0 [0 – 3] 349.5 0.486 
Polar Loop 2 
 Steps (number/day) 4568 [1444 – 7720] 9318 [8239 – 11717] 158 <0.001 
Intensity (min/day) 
Sedentary time  1244 [1121 – 1320] 1050 [991 – 1120] 116 <0.001 
Low intensity 162 [99 – 243] 329 [265 – 392] 105 <0.001 
Moderate intensity 13 [0 – 29] 24 [16 – 42] 242 0.009 
High intensity 0 [0 – 2] 1 [0 – 5] 318.5 0.151 
Abbreviations: IQR, interquartile range. 
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Agreement between Actigraph and Polar Loop 2 
ICC showed excellent agreement for number of steps recorded by the Actigraph and Polar Loop 2 
for both adults with CP and TD adults (Table 3). In addition, time spent in low, moderate and high 
intensity showed an excellent agreement for adults with CP, while only high intensity was excellent 
for TD adults. Time spent sedentary showed a good agreement between the Actigraph and Polar 
Loop 2 for both adults with CP and TD adults, as well as time spent in low and moderate intensity 
for TD adults. 
Table 3. Intraclass correlation coefficient (ICC) between Actigraph and Polar Loop 2 at different 
intensity levels for adults with CP and TD adults. 
Parameter Adults with CP TD adults 
ICC [95%CI] ICC [95%CI] 
Steps  0.95 [0.93 – 0.96] 0.97 [0.94 – 0.98] 
Intensity 
Sedentary 0.88 [0.83 – 0.91] 0.83 [0.77 – 0.87] 
Low intensity 0.92 [0.88 – 0.95] 0.87 [0.81 – 0.91] 
Moderate intensity 0.93 [0.91 – 0.95] 0.82 [0.75 – 0.86] 
High intensity 0.96 [0.94 – 0.97] 0.97 [0.96 – 0.98] 
Abbreviations: ICC, intraclass correlation coefficient; 95%CI, 95% confidence interval. 
Bland-Altman plots presented in Figure 1 illustrate the agreement between the Actigraph and Polar 
Loop 2 in estimating steps and time spent on different activity levels. The mean difference 
(Actigraph – Polar Loop 2) between the numbers of steps recorded was -536, indicating that on 
average the Polar Loop 2 recorded a lower number of steps. In 79% of the cases the value fell 
within ± 1.00 x SD and 93% fell within ± 1.96 x SD, showing acceptable agreement between the 
two accelerometers. Similar results were observed for the different levels of intensity, showing 
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mean differences of -3min for sedentary, 24min for low intensity, -3min for moderate intensity and 
-1min for high intensity. The highest agreement was observed for the time spent in high intensity,
showing that 91% of the cases fell within ± 1.00 x SD and 96% fell within ± 1.96 x SD, whereas the 
lowest agreement was observed for time spent in low intensity, in which 77% of the cases fell 
within ± 1.00 x SD and 94% fell within ± 1.96 x SD. 
Figure 1. Bland-Altman plots showing mean difference between Actigraph and Polar Loop 2 (thick line), ± 




The main finding of this study was that adults with CP were less physically active than TD adults. 
In addition, the Polar Loop 2 was found to be a valid measure for PA in adults with CP and TD 
adults. Adults with CP and TD adults included in the study were matched for gender, age, BMI and 
SES. 
According to the results of the current study it was found that adults with CP were less physically 
active than TD adults, based on the reduced number of steps taken per day, more time spent 
sedentary and less time spent in low and moderate intensity PA. On average, adults with CP spent 
86% of the day being sedentary, whereas TD adults spent 73% of the day sedentary. These 
relatively long periods of sedentary behaviour of adults with CP can be explained by the limitations 
that adults with CP have in movement and posture. In this study, a large proportion of adults with 
CP was dependent on walking aids or a wheelchair (GMFCS III-V), which makes it challenging for 
these adults to adhere to WHO guidelines given their limitations in physical functioning.9,17,29   
The current findings are supported by Ryan et al. (2014), who found that adults with CP spent more 
time being sedentary and spent less time in light and moderate PA.30 The study by Claridge et al. 
(2015) further emphasized that sedentary time was associated with GMFCS levels, indicating that 
adults with CP classified in GMFCS levels III-V spent more time being sedentary.17 In contrast, 
Van de Slot et al. (2007) found no differences in PA between adults with CP and TD adults. 
However, in that study only ambulant adults with CP and spastic hemiplegic adults were included, 
who showed minor physical impairments and spent on average 2hours and 32min per day in 
dynamic activities (i.e. walking, cycling, general movements). Unfortunately, the study of van der 
Slot et al. (2007) did not provide information about GMFCS levels.31 The majority of adults with 
CP in the current study did show physical impairments, i.e. 54% of adults with CP were classified 
in GMFCS III-V, which potentially caused the limited time spent in moderate to high intensity 
Research manuscript 
46 
physical activity of adults with CP 9 mins (0-30 mins) compared to TD adults 23 min (9-42 mins). 
Although adults with CP did not meet the recommended WHO guidelines for physical activity, TD 
adults included in current study had also failed to meet the guidelines. This is highlighted by the 
finding that, on average, adults with CP and TD adults did not show any difference in high intensity 
PA. The limited PA of TD adults could be caused by lower SES compared to previous studies, 
which were predominantly conducted in developed countries,30,31 implying a possiby decreased 
access to established health-care facilities. This is in contrast to the study by Ryan et al. (2014), 
who found that adults with CP, spent 5.2 min per day in high intensity PA.30 An explanation for the 
observed differences might be that Ryan et al. (2014) included adults with CP who were classified 
in GMFCS levels I-III, while a heterogeneous cohort of adults with CP classified in GMFCS levels 
I-V were included in the current study.
The substantially reduced PA levels in adults with CP compared to TD adults highlight the 
importance that PA should be addressed in rehabilitation or physical therapy From previous 
research among younger individuals with CP and adults with CP (unpublished), it is known that 
energy cost during walking is higher compared to TD peers. Training is therefore beneficial in two-
fold – it may increase the individual’s maximum functional capacity, thereby reducing the relative 
load, and it reduces the risk of metabolic diseases, pain and fatigue. 
Agreement between the Actigraph and the Polar Loop 2 was presented in this study to investigate 
the validity of the Polar Loop 2, in both adults with CP and TD adults. The ICC, between the two 
accelerometers showed that the Polar Loop 2 had a strong correlation with the Actigraph for the 
number of steps and across all PA intensity levels. Upon closer observation, the strongest correlates 
between the devices were found for the number of steps and in high intensity PA for both adults 
with CP and TD adults. In contrast, Leinonen et al. (2017), who investigated the validity of a 
different Polar device (Polar Active), found considerably lower ICC values when comparing it to 
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outcomes of the Actigraph, ranging from 0.078 for MVPA to 0.309 for sedentary time.28 The large 
differences in outcomes could be explained by the different Polar devices, i.e. the Polar Loop 2 
versus the Polar Active. In addition, a larger cohort was included in the current study, which may 
have increased the accuracy. 
The ICC results of the current study suggest that the Polar Loop 2 is a valid tool for assessing PA in 
both adults with CP and TD adults. In addition, Blant-Altman plots showed that the mean difference 
in the number of steps recorded and the times spent in different PA levels between the Actigraph 
and Polar Loop 2 is limited. However, the Bland-Altman plots also indicate that there is still a 
considerable variation between two devices for both adults with CP and TD adults, particularly in 
the time spent in low intensity PA (Figure 1). This finding indicates that in certain cases the Polar 
loop overestimated and in other cases underestimated the time spent in low intensity PA. The fact 
that this applies for both adults with CP and TD adults suggests that the variation between the 
Actigraph and Polar Loop 2 is not caused by the disabilities of adults with CP, for example in case 
individuals were wheelchair bound. Therefore, although the result of the current study suggests that 
the Polar Loop 2 is a valid tool for measuring PA in adult with CP and TD adults, it ought to be 
noted that variations in outcomes exist with the Polar Loop 2. Hence, ascertaining the need for 
further research with a heterogeneous cohort of adults with CP and a larger sample size in various 
GMFCS levels. 
Limitations 
Importantly, the relatively small sample size acts as a limitation. A larger sample size would enable 
distinguishing between GMFCS levels (e.g. wheelchair bound compared to ambulatory adults with 
CP), which may have an influence on validity. Therefore, future research could include a large 
matched sample size inclusive of GMFCS I-V, to confirm validity in subgroups using the Polar 




In summary, this study showed that adults with CP were less physically active than TD adults, 
based on findings that the number of steps taken per day were substantially lower, they spent more 
time being sedentary and less time in low and moderate intensity PA. The Polar Loop 2 showed to 
be a valid measure for PA in adults with CP and TD adults. The Polar Loop 2 is water-resistant and 
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1. Good publication practice
The journal follows the guidelines of the International Committee of Medical Journal Editors (www.icmje.org)
and Wiley's Best Practice Guidelines on Publication Ethics (www.wiley.com/bw/publicationethics/). In
particular, please note the following points.
a) Authorship
Our criteria for authorship are based on the International Committee of Medical Journal Editors guidelines.  More
information can be found here: www.icmje.org
Credit for authorship should be based on:
1. substantial contributions to research design, or the acquisition, analysis or interpretation of data;
2. drafting the paper or revising it critically;
3. approval of the submitted and final versions.
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The corresponding author must state that all the authors have read the manuscript and agreed to its being
submitted for publication. The covering letter should state that all individuals listed as authors meet the
appropriate authorship criteria, that nobody who qualifies for authorship has been omitted from the list, that
contributors and their funding sources have been properly acknowledged, and that authors and contributors have
approved the acknowledgement of their contributions. The covering letter should include a short description of
each author’s contribution and should state whether he or she had complete access to the study data that support
the publication.
Up to ten authors may be included on the title page. When there are more than ten authors, nine may be included
on the title page and the tenth slot given to an appropriately named group; the members of this group will be listed
in an appendix published online only. The authors listed in the study group will still be recognised as collaborators
of the paper in search engines such as PubMed.
Contributors who do not qualify as authors should be listed, and their contribution described, in an
acknowledgement section at the end of the article.
b) Reporting guidelines:
For all Original Articles, Systematic Reviews, and Meta-analyses, the Editors and Editorial Board require that
authors follow the guidelines of the Equator network when reporting research methods and findings
(http://www.equator-network.org/library/).
 
We strongly recommend the authors conduct all original research, Systematic Reviews, and Scoping Reviews, based
on an appropriate pre-established protocol.
 
Submissions must be accompanied by the appropriate checklist, fully completed with page numbers where
applicable. Please select the most suitable checklist from the following and download the appropriate checklist:
Observational studies (i.e. most Original Articles): STROBE guidelines 
Systematic Reviews or Meta-analyses: PRISMA checklist (for all systematic reviews) and AMSTAR-2
checklist (for all systematic reviews of interventions)
Scoping reviews: PRISMA-ScR 
Randomized controlled trials: CONSORT guidelines
Other types of study e.g. Diagnostic Accuracy: please visit the Equator website http://www.equator-
network.org/library/
 
For Editorials, Commentaries, Book Reviews, other types of Review (i.e. not Systematic), Case Series, and Letters,
no checklist is required.
c) Registration of clinical trials, systematic reviews, and scoping reviews
If publishing the results of a clinical trial or systematic review, please include the clinical trial registration number.
All trials should be registered in a publicly accessible database such as PROSPERO, ClinicalTrials.gov, ICMJE,
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and WHO. Scoping reviews should be registered in a publicly accessible database such as the Joanna Briggs
Institute. Scoping Reviews in the Joanna Briggs Institute Reviewer's Manual.
Please upload a copy of the trial protocol as a supplementary file.
d) Duplicate or related submission
Authors should declare that the submitted work and its essential substance have not previously been published and
are not being considered for publication elsewhere. Manuscripts must not be submitted simultaneously to another
journal. All suspected cases of multiple submissions or redundant publication will be subject to investigation.
If other aspects of the same study were reported previously, are in press, or currently submitted elsewhere, this
must be clearly indicated in the Methods section, with full referencing.
e) Approval and consent
Ethical approval
Authors of research articles should demonstrate that the research has been approved by a named research ethics
committee, that the committee’s recommendations have been adhered to, and that written informed consent for
participation and publication has been obtained.
Please include a statement in the text of your paper to indicate that ethical approval has been given and give the
name of the body (research ethics committee, institutional review board etc.) that approved the study.
If the institution’s research ethics committee did not consider that their approval was needed, this should be stated
in the text.
Consent
Please indicate in the text that patients or their carers have given informed consent to the research and to
publication of the results.
If recognizable photographs or verbal descriptions of an individual are used in an article, written consent from the
appropriate person(s) for publication must be submitted to, and kept by, the author. All case series and clinical
photographs require consent. Names, initials, or any other means of identification should not be shown on any
photograph. Please use the Consent Form available from the DMCN submission site (Click here).
f) Disclosures and funding
Disclosures of interest must be made during the online submission process for authors and during the review
process for referees. During the online submission process, you will need to clarify the involvement of any funder
in study design, data collection and analysis, and manuscript preparation. It is mandatory that a DMCN Disclosure
Form is completed when your paper is submitted, and your paper will not be sent for review until we have received
your form. ALL authors must sign the DMCN Disclosure Form before their paper will be published. The form
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should be submitted to the Editorial Office with your manuscript. The DMCN Disclosure form can be found on
the submission site (http://mc.manuscriptcentral.com/societyimages/dmcn/Author-Disclosure-Form-
August%202018.docx).
All authors and referees must provide details of financial interests in any company or institution that might benefit
from the publication of the article. Authors and referees should also declare any other potential competing
interests that readers or editors might consider relevant to the research submitted for publication. In making
disclosures, please consider these three areas (please refer to http://www.icmje.org/ethical_4conflicts.html for
further information):
1. Financial payments to you or your institution from any sources that might benefit from publication of your
submission, and any other relevant financial interests (e.g. employment, significant share ownership, patent
rights, consultancy, research funding);
2. Similar financial relationships involving your spouse or partner or your dependent children;
3. Any personal, professional, political, institutional, religious, or other associations that a reasonable reader
would want to know about in relation to the submitted work.
All sources of funding or support should be noted in the acknowledgements section of the manuscript (including
grants from funding bodies, sponsorship or grants from commercial organisations, and donation of materials).
Please note that authors’ disclosures as submitted will be reproduced at the end of your paper when it is
published.  If no disclosure is made, the following statement will be added to your paper: “The authors have stated
that they had no interests which might be perceived as posing a conflict or bias.”
 
g) Misconduct
If suspicion of misconduct is raised after publication a statement of concern may be issued. All complaints or
concerns will be investigated. Serious cases of misconduct would result in retraction. DMCN follows the Wiley
retraction guidelines. More information can be found here:
http://authorservices.wiley.com/bauthor/faqs.asp#policy.
2. Copyright
Authors must declare that the work submitted is their own and that copyright has not been breached in seeking its
publication.  If the manuscript includes work previously published elsewhere, it is the authors’ responsibility to
obtain permission to use it and to indicate that such permission has been granted.
Please note that all papers will be assessed using iThenticate® which checks written work for duplicate and
unattributed content against a large comparison database in order to ensure work is original before publication.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an
email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they
will be able to complete the license agreement on behalf of all authors on the paper.
8/30/2019 Developmental Medicine & Child Neurology
https://onlinelibrary.wiley.com/page/journal/14698749/homepage/forauthors.html 6/15
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer
agreement (CTA) to sign. The terms and conditions of the CTA can be previewed at the following link: CTA
Terms and Conditions here. Please do not complete this PDF until you are prompted to login into Author
Services as described above.
Note to Contributors on Deposit of Accepted Version
Funder arrangements
Certain funders, including the NIH, members of the Research Councils UK (RCUK), and Wellcome Trust require
deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set
out at the following website: http://www.wiley.com/go/funderstatement. Please contact the Journal
production editor at DMCN@wiley.com if you have additional funding requirements.
Institutions
Wiley has arrangements with certain academic institutions to permit the deposit of the Accepted Version in the
institutional repository after an embargo period. Details of such arrangements are set out at the following website:
http://www.wiley.com/go/funderstatement.
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative
Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on
Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit
http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the
Research Councils UK (RCUK), you will be given the opportunity to publish your article under a CC-BY license
supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information
on this policy and the Journal’s compliant self-archiving policy please visit:
http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this
license:
Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on
Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit
http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html
3. Presentation and formatting of your paper
a) Maximum length requirements
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(excl refs)
Original article Structured, 
200 words










1 to 5 points ¾ As appropriate ¾ Required
Invited review Unstructured,
150 words






1 to 5 points 3000 30 4 No
Case series Unstructured,
150 words
1 to 2 points 1500 15 2 No
Letter to the
Editor




None None 600 5 0 No
b) All papers
Title page Include the title of the paper, authors’ full names, main appointments and primary affiliations, and
word count. Identify the corresponding author and give his or her postal address, and e-mail address.
We encourage corresponding authors to provide an ORCID (Open Researcher and Contributor ID) identifier.
ORCID is a registry that provides researchers with a unique digital identifier. Some funding agencies recommend
or even require the inclusion of the ORCID in all published articles, and authors should consult their funding
agency guidelines for details. Registration is easy and free (for further information, see http://orcid.org/).
Abstract On the second page of original articles and systematic reviews, provide a full structured abstract of no
more than 200 words, with the following headings: Aim; Method, Results, Interpretation. The abstract should use
plain language, as it will be available openly—that is, independent of the main paper. The Aim section should
focus exclusively on the objective of the paper. Where relevant the Method section should follow Equator
guidelines (http://www.equator-network.org/), and should include means (SD) or  medians and sample size,
and sex for study and control groups, definition of clinical characteristics, entry criteria for study, assessments used,
duration and frequency of intervention, and timing of outcome assessments. Where relevant Results should follow
Equator guidelines and should summarize significant results with statistical values, including negative findings if
related to the study hypothesis. Non-significant trends should not be noted in the abstract. In the Interpretation,
authors should consider addressing what their findings add to the understanding of the topic.
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Non-systematic reviews and case series should have a non-structured abstract without headings of up to 150
words, covering the aims, method, results, and conclusions of the study.
On the abstract page, also provide a shortened form of the title (up to six words) for use as a running footer.
‘What this paper adds’ All original articles and systematic reviews should have a section ‘What this paper adds’
after the abstract. This should comprise up to five bullet points up to 12 words. Other articles should have one or
two similar bullet points.
The bullet points should contain only new results offered by the paper (i.e. not the paper’s design or implications),
presented in a direct way. They should be succinct, and preferably they should use plain language because the
‘What this paper adds’ section will be openly accessible (that is, free to view by anyone).
General Include tables and figure legends in your main article file, after the references. Submit figures
(illustrations) as separate files, as described below. Name all files using the surname of the first author (e.g.
Smith.doc, Smith fig1.tif, etc.).
Common Data Elements We encourage the authors of papers relating to research on cerebral palsy to use the
Common Data Elements suggested by the National Institute of Neurological Disorders and Stroke and American
Academy for Cerebral Palsy and Developmental Medicine
(https://onlinelibrary.wiley.com/doi/10.1111/dmcn.13723).
c) Original articles
Articles should comprise an introductory section (but not headed ‘Introduction’), followed by ‘Method’ (with
optional subheadings, such as ‘Participants’ (rather than ‘Subjects’) and ‘Statistical analysis’), ‘Results’, and
‘Discussion’ sections. The Discussion section should include the limitations of the study. Subheadings should
otherwise be kept to a minimum.
Authors are encouraged to submit video material supporting their papers, where appropriate, for publication in the
Journal.
Papers longer than 3000 words, such as those reporting randomized controlled trials, may be published at the
Editors’ discretion.
Randomized controlled trials should include a short trial protocol as supplementary information.
We encourage the inclusion of a graphical abstract which captures the content of the article for readers at a single
glance.
d) Reviews
We publish three types of review. Please refer to the 'Reporting guidelines’ section for reporting guidelines and
protocol registration.
8/30/2019 Developmental Medicine & Child Neurology
https://onlinelibrary.wiley.com/page/journal/14698749/homepage/forauthors.html 9/15
1. Systematic review: a type of research synthesis of quantitative evidence that uses pre-defined, explicit,
systematic methods selected to minimize bias and provide reliable findings on which to make decisions. A
systematic review answers a precise, pre-stated question based on the PICO/PICOT (Population, Intervention,
Comparator, Outcome [and Treatment]) elements. Quality assessment of the evidence both within the review and
across the included studies is essential in order to analyse the risks of bias and gauge the degree of confidence that
can be had in its conclusions.
We publish three types of review. Please refer to the 'Reporting guidelines’ section for reporting guidelines and
protocol registration.
A systematic review must be carried out following a pre-established protocol that is registered on a public registry,
such as:
- PRISMA-P
We require the use of an appropriate quality appraisal tool, such as:
- Critical Appraisal Skills Programme (CASP) relevant checklist(s)
- Joanna Briggs Institute (JBI) relevant tool(s)
- Grading of Recommendations Assessment, Development and Evaluation (GRADE)
Should quality of included articles be felt to be sufficient, then a protocol for defining levels of evidence should be
followed, such as:
- Centre for Evidence-Based Medicine (CEBM) levels of evidence
We require the inclusion of a graphical abstract which captures the content of the article for readers at a single
glance.
2. Scoping review: similar to the systematic review in terms of systematic approach, rigor, and transparency but
with a broader, preliminary approach. The goal is to ‘scope out’ available evidence in emerging clinical areas and
the research question is less precise than that of a systematic review. The results of the review are charted to give
an overview of the current state of research as well as to identify gaps in the evidence to guide future research.
Quality assessment of the evidence is encouraged, in order to most effectively identify gaps in the existing body of
evidence. We require the inclusion of an evidence map which visually identifies gaps in knowledge and/or future
research needs, capturing the content of the article for readers at a single glance.
For more information authors are advised to read the chapter on Scoping Reviews in the Joanna Briggs Institute
Reviewer's Manual.
3. Review: a narrative review providing the reader with up-to-date information about the subject in question in a
relatively brief format, referring to significant papers but not forming a systematic overview of the literature.
Authors are advised to refer to the paper by Grant et al: A Typography of Reviews published in Health Information
and Libraries Journal, 2009, 26:2, before submitting a review paper to DMCN.
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e) Clinical practice guides
Clinical practice guides are developed to assist practitioners with appropriate health care and informed decision
making for specific clinical circumstances. If appropriate they should include relevant clues to diagnosis, including
differential diagnosis, and management. Photo and video illustrations are welcome. some of the information can
be synthetized in tables and algorithm.  
f) Case series
DMCN accepts a very limited number of case series (not single case reports). These should significantly add to our
understanding of a condition or present a novel finding. They should comprise an introductory section as above,
followed by the ‘Case Report’, then a ‘Discussion’ section.
g) Letters to the Editor
Letters are published at the Editors’ discretion. They may comment on a published paper, or raise issues that are
new to DMCN. In the case of letters commenting on a published paper, usually the author of that paper will be
invited to comment on the letter, with both letter and comments being published in the same issue. The editor
may suggest the letter is made available online on the Mac Keith Press website, without formal publication, to
encourage debate (see http://www.mackeith.co.uk/journal/letters-to-the-editor/).
h) References
The Vancouver style is used, as recommended by the International Committee of Medical Journal Editors. Cite
using a superscript number in the text, with a numerical list of references at the end of the paper presented in
order of citation. Cite only peer-reviewed, published material. The journal does not recognize abstracts or
submitted (as opposed to accepted, or ‘forthcoming’) papers as proper citations; such material should not be listed
with the references but cited only in text, followed by ‘(personal communication)’.
List all authors unless more than six, in which case list the first three followed by ‘et al.’, using Index Medicus
abbreviations for journal names (see www.nlm.nih.gov/tsd/serials/lji.html). Order and punctuate
bibliographic information as follows, omitting issue month and number unless needed to distinguish issues. For
additional citation formats, adapt appropriate examples from the NLM’s Citing Medicine
(www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=citmed).
Journal Article
Abrams RA, Tsai AM, Watson B, Jamali A, Lieber RL. Skeletal muscle recovery after tenotomy and 7-day
delayed muscle length restoration. Muscle Nerve 2003; 23: 707–14.
Auvin S, Joriot-Chekaf S, Cuvellier JC, Vallée C. Familial alternating hemiplegia of childhood or
channelopathy? [letter]. Dev Med Child Neurol 2004; 46: 500.
Journal Article, online only
High PC; the Committee on Early Childhood, Adoption, and Dependent Care and Council on School
Health. School readiness. Pediatrics 2008; 121: e1008–15.
8/30/2019 Developmental Medicine & Child Neurology
https://onlinelibrary.wiley.com/page/journal/14698749/homepage/forauthors.html 11/15
Journal Article, e-pub/online early
Forsyth R, Basu AP. The change we want to see: the promotion of recovery after acquired brain injury. Dev
Med Child Neurol 2014 Sep 8. doi: 10.1111/dmcn.12575. [Epub ahead of print].
Book, whole
Mesibov GB, Kunce L, Schopler E. Asperger syndrome or high functioning autism? Current issues in
autism. New York: Plenum Press, 1998.
Book, chapter
Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman RA, Nelson NM, editors.
Primary pediatric care. 2nd edition. St. Louis: Mosby Yearbook, Inc., 1992: 1367–78.
For references to online sources, supply the author names, full title, and full URL including the date on which the
site was accessed.
i) Figures and tables
Note that the Editors may decide that large figures or tables should be published online-only.
Tables, figure legends and short appendices Set out on separate pages at the end of (and as part of) the main
document, after the references.
Tables and appendices to be published online only Present as separate files in Microsoft Word or Rich Text
format.
Figures (e.g. illustrations, charts and photographs) Present electronically as separate files (not in the main text of
the article). Guidelines about acceptable file formats and illustration preparation are provided at
authorservices.wiley.com/bauthor/illustration.asp.
Please label radiographs, CT, or MRI scans with left [L] and right [R], and if appropriate with anterior [A] and
posterior [P]. Areas of interest should be marked with an arrow. For EEGs please indicate the gain, timescale, and
lead position.
Graphs should be as simple as possible, not three-dimensional, and not framed. Shading should be white, black, or
strong hatching, not grey. No background lines should be used (except for bars and axes).
Colour If colour printing of figures is essential for their comprehension, please indicate this in the covering letter.
There is normally a charge to the author for printing in colour. It is possible to publish a figure in black and white
in the print version of the issue but in colour in the online version at no extra charge. However, please ensure that
the figures are suitable for reproduction in both colour and black and white – for instance, use colours that are
distinguishable from each other when converted to greyscale and avoid describing colour in the caption. The
figures must be understandable to readers of the print edition, who may not have access to the articles online.
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If the author supplies colour figures, at Early View publication they will be invited to complete a colour charge
agreement in RightsLink for Author Services. The author will have the option of paying immediately with a credit
or debit card, or they can request an invoice. If the author chooses not to purchase colour printing, the figures will
be converted to black and white for the print issue of the journal.
Figures should be numbered in order in the text.  A caption must be supplied for each figure.  The caption should
not repeat what is written in the text material and should follow the Journal style (please refer to recent issues for
examples).  All captions should be placed in a list at the end of the main document. Please remember to supply
captions for figures that will be published electronically.  The caption must describe all labels in a figure.  For
images, the caption should include the type of image, its plane, whether or not contrast material was used, the
pulse sequence information for MR images and the features to be observed by the reader.  However, full details of
the MR sequences should be described in the methods section, not in the caption.
j) Statistical reporting
The Editors advise reading “Statistical recommendations for papers submitted to Developmental Medicine & Child
Neurology” (Rigby AS, Dev Med Child Neurol 2010; 52: 299–304) for guidelines on appropriate use and
reporting of statistical analyses. Authors are recommended to work with a statistician where appropriate.
k) Supporting information (supplementary material)
DMCN publishes online supporting information (including audio and video files, data sets, additional images, and
large appendices) that cannot be included in the print version of an article. This material should be relevant to and
supportive of the parent article. For guidelines see authorservices.wiley.com/bauthor/suppmat.asp.
Authors are encouraged to submit video material to support their papers (e.g. to demonstrate techniques or
methods, or to demonstrate a randomized controlled trial protocol).
 
4. Selection and publication
a) Editorial review
Submissions are subjected to an editorial discussion about their general suitability for the journal. This may lead to
the decision to not accept the paper, or to send for review by at least two independent referees. During the
submission process, authors have the opportunity to suggest up to three suitable independent referees (with their
contact details), but the choice of referee rests with the Editors. At a later stage in the review process, papers with
statistical analyses undergo specific statistical review.
Editors and editorial board members are not involved in editorial processes or decisions about their own work.
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Reviewers are asked to disclose potential conflicts of interest when they are invited to review a paper and when
they submit their review.
Papers thought to have immediate, clinically important consequences may be considered for fast-track publication.
The decision to prioritize remains with the Editors.
b) After acceptance
After acceptance, authors will be able to track the progress of their article through production to publication by
registering for Author Services with Wiley. Authors will be sent information about how to register for Author
Services once their article has been accepted.
When an accepted paper has been copy-edited and proofed authors will receive a PDF proof. When this has been
approved by the authors and the paper is ready for publication, it will normally be posted online in the journal’s
‘EarlyView’ section before allocation to an issue.  EarlyView articles are in their final form and are fully published
and citable.
Authors receive a free PDF of the paper soon after publication via Author Services. Reprints may be ordered when
returning proofs. Please send no payment: an invoice will be sent shortly after you receive the reprints.
c) After publication
Authors are encouraged to promote their articles, for example, through social media.
If errors affecting the interpretation of data or information are discovered after publication, an erratum will be
published in the next available issue of the journal and published online.
5. Style points
Jargon Avoid it strenuously. The journal aims to communicate across disciplines, and many of its readers do not
have English as their first language, so plain language is preferred. The Editors may clarify and shorten
manuscripts accepted for publication as necessary.
Abbreviations These should be kept to a minimum and restricted to those that are generally recognised. They
must be spelled out in full on first usage in text and again in figure captions and table footnotes. They should be
avoided in titles, headings and subheadings.
Participant details Give mean (SD) age in years and months (not decimal years) and gender (n, not %). Ensure
this information is included in the abstract. In the text, indicate where study and comparison groups are from and
how participants were selected.
Measurements Use SI units, except for blood pressure (mmHg); convert imperial units to metric. Do not use
percentages for sample sizes below 50; use the symbol ‘%’ in tables. Show standard deviations as (SD), not ±.
Abbreviate probability with a lower case italicized p, and provide to 3 decimal places when possible.
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Numbers In general, use numerals, but spell out numbers at the beginning of sentences. Spell out numbers ‘one’
to ‘nine’ if they refer to nouns that are not units of measurement, e.g. ‘The results from four children confirm the
findings’. For ages and time periods, use years, months, weeks and days, not decimals (e.g. 5 years 3 months, not
5.25 years).
Equipment and drugs Include (in parentheses) the name of the manufacturer, the city, and country of
production.
Terminology We favour person-first language eg ‘individuals with cerebral palsy’. We no longer use ‘mental
retardation’, but rather ‘intellectual disability’ for example. Rather than ‘normal children’ etc, we use ‘typically
developing’, ‘population norms’, etc. We also avoid the term ‘race’, which has no scientific basis for divisions into
biologically determined groups and is a poor proxy for better defined socio-demographic or genetic categories.
Instead, use predefined population categories or ‘ethnic group’.
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